
	Search		Keep Me Updated		Tell a Friend		Add to My Favorites

PRELIMINARY SCIENTIFIC PROGRAM

Section: Drug Development
Toxicology	Back To Section List
Chairperson: F. Fraunfelder, USA
Rapamycin (Sirolimus) for the Treatment of Retinal Diseases A. Laties, USA
Firm evidence of Viagra Ocular Side Effects F. Fraunfelder, USA
Update on Ocular Pharmacoviglience R. Fraunfelder, USA

Drug Delivery	Back To Section List
Chairpersons: R. Gurny, Switzerland, D. Tang-Liu, USA
Nanoparticles for Gene Delivery to the Eye U.B. Kompella, USA
Modelling Considerations of Ocular Drug Delivery to the Back of the Eye S. Lee, USA
Intraocular Delivery of Nucleic Acids Using Trojan Delivery Systems E. Fattal, France
Delivery of Topically Applied Antibody Fragments to the Back of the Eye D. Urech, Switzerland
Medicated Intraocular Lenses Y.J. Guex-Crosier, Switzerland
Cationic Emulsions: Potential Ocular Nanocarriers for Antisense Oligonucleotides S. Benita, Israel
Water-Soluble Cyclosporine - A Prodrug for the Delivery to the Eye L. Bossy, Switzerland
The Impact of Melanin on Ocular Kinetics C. Wilson, UK

Nanotechnology	Back To Section List
Chairperson: C.A. Paterson, USA
Developing Nanotechnology Based Approaches for Repairing Retina and Optic Nerve M. De Silva, USA
Nanotechnology Based Adhesives for Corneal Wound Repair M. Grinstaff, USA
The Impact of Nanotechnology on Eye Treatments R. Ellis-Behnke, USA

Latest Advances in Ocular Drug Discovery	Back To Section List
Chairpersons: T. Yorio, USA G. Prasanna, USA
Opioid Agonists: Potential Therapy for Ischemic Retinal Disorders C. Crosson, USA
Sigma Receptor and Neuroprotection T. Yorio, USA
RNA Interference: Promising New Therapy for Ocular Disorders R. Patil, USA
Biomarkers in Ocular Drug Discovery G. Prasanna, USA

Clinical Research Network in Ophthalmology. Need for Standardized Quality	Back To Section List
Chairperson: J. Cunha-Vaz, Portugal
DRCR.net (USA) B. Kuppermann, USA
EVI.CT.SE (EU) J. Cunha-Vaz, Portugal
CRO Perspective I. Schauwecker, Switzerland (Appletree, Switzerland)
EMEA Perspective K. Wickström, Sweden
FDA Perspective on Medical Devices M. Eydelman, USA

Site Map